Aug 26, 2020 / 10:00PM GMT
Presentation
Aug 26, 2020 / 10:00PM GMT
=====================
Corporate Participants
=====================
* Fred Grossman
Mesoblast Limited - Chief Medical Officer
* Josh Muntner
Mesoblast Limited - CFO
* Silviu Itescu
Mesoblast Limited - Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director
=====================
Conference Call Participants
=====================
* Jason Howard Kolbert
Dawson James Securities, Inc., Research Division - Director of Research
* Jeffrey Scott Cohen
Ladenburg Thalmann & Co. Inc., Research Division - MD of Equity Research
* Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
* Swayampakula Ramakanth
H.C. Wainwright & Co, LLC, Research Division - MD of Equity Research & Senior Healthcare Analyst
* Tanushree Jain
Bell Potter Securities Limited, Research Division - Healthcare and Biotech Analyst
=====================
Operator<
Mesoblast Ltd
(ASX:MSB)
A$
2.41
+0.050 (+2.12%)
Market Cap: 3.06 Bil
Enterprise Value: 3.07 Bil
PE Ratio: 9,999.00
PB Ratio: 3.36
GF Score: 39/100 Full Year 2020 Mesoblast Ltd Earnings Presentation Transcript
Aug 26, 2020 / 10:00PM GMT
Release Date Price:
A$4.88
(-1.72%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot